Karina Dalsgaard
@DalsgaardKarina
Followers
71
Following
103
Media
0
Statuses
49
Joined April 2014
NOW ONLINE @DalsgaardKarina & team at @AarhusUni unveil the potential of liquid biopsies for detailed genomic analysis in advanced/aggressive #ProstateCancer. A promising alternative to traditional tissue biopsies! 🔓OPEN ACCESS ➡️ https://t.co/U9muxx1Hf9
0
3
3
Open two-year postdoc position in translational precision oncology https://t.co/8JMvcFZ3jZ
linkedin.com
Looking for a #postdoc position? We've got an opening for a 2-year position in Translational Precision Oncology at Dept. of Molecular Medicine, Aarhus University Hospital. For more information,...
0
3
4
Is there a way for prognostic tools to distinguish between indolent and aggressive #ProstateCancer (PC)? A Aarhus University Hospital (@AUHdk) team demonstrates the potential of stromal signatures in the identification of clinically relevant PC subtypes. https://t.co/ajsLfE0Xr5
0
2
3
Postdoc wanted! Two-year postdoc position in liquid tumor biopsy sequencing and prostate cancer (epi)genomics in Sørensen group @DalsgaardKarina. Application deadline: March 25th https://t.co/50BS2aO9Ir
au.dk
Ledig stilling ved Institut for Klinisk Medicin - Molekylær Medicinsk afdeling (MOMA), Aarhus Universitet
0
3
2
Lav-risiko prostatakræft kan alligevel ende med at kræve operation i op til hver tredje patient. @EvaFerlev vil udvikle en molekylær risiko-signatur for at kunne skræddersye den rigtige behandling og overvågning. Tak til NEYE-fonden for støtte!🙏 Læs mere: https://t.co/97RHb5d9vv
0
1
7
Our study on the impact of germline DNA repair gene variants on the prognosis and treatment of men with advanced #prostatecancer has now been published. @EmmaBollmann
@DalsgaardKarina
https://t.co/ucq6mxNPcl
nature.com
Scientific Reports - Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer
0
1
5
Happy to share that the results from the PRIMA trial have just been published. It is the culmination of a project that involved more than 2000 patients, where we tested if the STHLM3 test would be a better for detection of prostate cancer than PSA.
0
2
11
Researchers at @iNANO_AarhusUni and @moma_dk at @AUHdk join forces to move #prostatecancer #immunotherapies closer to the clinic by using Albumin-fused T-cell engagers. @DalsgaardKarina
https://t.co/RTo35C7VnY
inano.au.dk
Despite numerous trials in the past decade prostate tumors have so far resisted treatment with immunotherapy. Now iNANO and Aarhus University Hospital researchers join forces to move prostate cancer...
0
2
4
New drug design may be a step towards developing long-awaited #Immunotherapy against #prostatecancer. Researchers from iNANO, @MolBiolAU, and @AUHdk join forces in using Albumin-fused #Tcell engagers as potential immunotherapy. #CancerResearch #Cancer
https://t.co/pSbv8g9sLq
0
3
8
A new study from @DalsgaardKarina & co-workers shows that loss of PARP1, ARH3, YWHAE or UBR5 is associated with PARP inhibitor resistance in castration resistant #ProstateCancer. 👉
0
3
3
Dr. Karina Dalsgaard (@DalsgaardKarina) and colleagues from @AarhusUni_int used a genome-wide #CRISPR-Cas9 knockout 🥊 screen to identify genes involved in poly(ADP-ribose) polymerase inhibitor resistance in castration-resistant prostate cancer. https://t.co/K8TzAtW1Qp
0
4
16
Our study on the use of non-negative matrix factorization on circulating tumor DNA is out in elife! w @SBesenbacher @moma_dk @DTU_HealthTech
elifesciences.org
Non-negative Matrix Factorization is a powerful strategy for unsupervised analysis of cell-free DNA that enables simultaneous estimation of the blood tumor fraction and the fragment length distribu...
0
10
18
Vi tilbyder stilling(er) som klinisk akademiker @DkDska i vores diagnostiske gruppe til fortolkning af somatiske varianter i targeteret kræftbehandling og kliniske #ctDNA analyser. Ansøgningsfrist 20.2. https://t.co/DO1M00yyf0
0
4
12
Vi tilbyder stilling(er) som klinisk akademiker @DkDska i vores diagnostiske gruppe til fortolkning af somatiske varianter i targeteret kræftbehandling og kliniske #ctDNA analyser. Ansøgningsfrist 20.2. https://t.co/DO1M00yyf0
0
7
13
Exciting #prostatecancer research double feature! @DalsgaardKarina and co @AarhusUni_int present TWO new manuscripts investigating 1) the prostate tumor #microbiome and 2) the prostate cancer #circRNA landscape. Read here! 1) https://t.co/NUHh5mwmBY 2) https://t.co/ThANo6TBpe
0
7
14
Ny professor: Vi kan diagnosticere prostatakræft tidligere @DalsgaardKarina på @AUHdk går fra et MSO professorat til et fuldt professorat på @AarhusUni. Hun forsker i nye metoder til at diagnosticere prostatakræft og målrette behandlingen. #sundpol #dkvid
https://t.co/0pUERtoXa8
1
2
25
New preprint out on detection of ctDNA fragment length signatures using NMF with @SBesenbacher @gabrielylr @MaibrittNor @DalsgaardKarina @ClausLindbjerg and other good people:)
biorxiv.org
Sequencing of cell-free DNA (cfDNA) is currently being used to detect cancer by searching both for mutational and non-mutational alterations. Recent work has shown that the length distribution of...
0
9
14
Very proud of my student Ea - you did a great job today 😊 Huge congratulations also to Mateo and his supervisor @nbirkbak
Ea Marie Sørensen and PhD student Mateo Sokač will defend their Master of Science/part A thesis today. Ea has investigated olaparib resistance mechanisms in advanced #prostatecancer while Mateo looked into #AI in #precisionmedicine. @DalsgaardKarina @nbirkbak
0
0
0
Well done - you both did a great job yesterday. Congratulations from your proud supervisor 😊
Two MSc defenses today - we wish you good luck! PhD student Emma B. Laursen about ”Circular RNAs in #ProstateCancer and Their Potential as Clinical Biomarkers” and Martin Rasmussen about "Investigating the tumor microenvironment of localized prostate cancer". @DalsgaardKarina
0
0
4
Jakob Haldrup will defend his PhD thesis on “Identification of molecular drivers of prostate cancer aggressiveness and drug resistance” tomorrow, June 19th at 14:00. Feel free to join via Zoom. 👉 https://t.co/VhgYm7b2I3
@JakobHaldrup #prostatecancer @AarhusUni
0
1
8